For customers outside of Japan
Our Manila office opened in 2004, serving the third-largest pharmaceutical market in the ASEAN region. The Philippines is well positioned for future growth that will largely be driven by the government continuing to encourage the use of generics while improving the regulatory environment to attract foreign investment. In particular, clinical research into vaccinations used to prevent tropical diseases is an area that is bound to expand, due in part to the field having been neglected for many years and because of the availability of a large patient pool.
Health Expenditure per Capita
(2018, US$)
$124
Source: Financing Global Health Database 2018
Population(2019)
108
million people
Source: The World Bank
Burden of Disease DALYs Causes % of Total DALYs
(2017, all ages/both sexes)
Ischemic heart disease (7.93%)
Neonatal disorders (7.54%)
Lower respiratory infections (7.08%)
Source: Institute Health Matrics and Evaluation GBD
NDA Approval Time
12
months
18
months
Clinical trial regulations in the Philippines: application and protocol approval
Clinical trial regulations in the Philippines are now of the utmost importance. The number of clinical trials conducted has increased substantially over the years. In 2009 alone, the Philippines saw a 30.9% increase in clinical trials conducted ...
Neglected tropical diseases and rabies: the struggles of the Philippine government
The Philippines has long been plagued by neglected tropical diseases (NTDs) such as schistosomiasis, soil-transmitted helminthiasis, leptospirosis, dengue and rabies. Poorer rural communities are disproportionally impacted ...
Contact Us
Monitoring
Share this page